Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | adenosine deaminase, putative | 0.7565 | 1 | 1 |
Mycobacterium leprae | Probable adenosine deaminase Add (ADENOSINE AMINOHYDROLASE) | 0.7565 | 1 | 0.5 |
Trypanosoma cruzi | AMP deaminase, putative | 0.4387 | 0.5741 | 1 |
Schistosoma mansoni | adenosine deaminase-related | 0.7565 | 1 | 1 |
Plasmodium vivax | adenosine deaminase, putative | 0.7565 | 1 | 1 |
Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.7565 | 1 | 1 |
Echinococcus granulosus | nmda type glutamate receptor | 0.0136 | 0.0046 | 0.0046 |
Trichomonas vaginalis | adenosine deaminase, putative | 0.7565 | 1 | 0.5 |
Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.7565 | 1 | 1 |
Trypanosoma cruzi | AMP deaminase, putative | 0.4387 | 0.5741 | 1 |
Trypanosoma cruzi | adenosine monophosphate deaminase, putative | 0.4387 | 0.5741 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.4578 | 0.5997 | 0.5155 |
Trichomonas vaginalis | adenosine deaminase, putative | 0.7565 | 1 | 0.5 |
Trypanosoma brucei | AMP deaminase, putative | 0.4387 | 0.5741 | 0.5 |
Schistosoma mansoni | adenosine deaminase | 0.7565 | 1 | 1 |
Leishmania major | AMP deaminase, putative | 0.4387 | 0.5741 | 0.3057 |
Loa Loa (eye worm) | hypothetical protein | 0.2987 | 0.3866 | 0.2575 |
Treponema pallidum | adenosine deaminase | 0.7565 | 1 | 0.5 |
Schistosoma mansoni | AMP deaminase | 0.4387 | 0.5741 | 0.5733 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.0107 | 0.0007 | 0.0007 |
Leishmania major | AMP deaminase, putative,adenosine monophosphate deaminase-like protein | 0.4387 | 0.5741 | 0.3057 |
Loa Loa (eye worm) | hypothetical protein | 0.7565 | 1 | 1 |
Onchocerca volvulus | Adenosine deaminase homolog | 0.7565 | 1 | 1 |
Onchocerca volvulus | AMP deaminase 2 homolog | 0.4387 | 0.5741 | 0.3057 |
Echinococcus granulosus | adenosine deaminase | 0.7565 | 1 | 1 |
Plasmodium falciparum | adenosine deaminase | 0.7565 | 1 | 1 |
Mycobacterium tuberculosis | Probable adenosine deaminase Add (adenosine aminohydrolase) | 0.7565 | 1 | 0.5 |
Trypanosoma cruzi | AMP deaminase, putative | 0.4387 | 0.5741 | 1 |
Echinococcus granulosus | AMP deaminase 2 | 0.4387 | 0.5741 | 0.5741 |
Trypanosoma cruzi | AMP deaminase, putative | 0.4387 | 0.5741 | 1 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.0136 | 0.0046 | 0.0046 |
Loa Loa (eye worm) | hypothetical protein | 0.4578 | 0.5997 | 0.5155 |
Trypanosoma cruzi | AMP deaminase, putative | 0.4387 | 0.5741 | 1 |
Mycobacterium ulcerans | adenosine deaminase | 0.7565 | 1 | 0.5 |
Leishmania major | adenine aminohydrolase | 0.7565 | 1 | 1 |
Trypanosoma cruzi | adenosine monophosphate deaminase-like protein, putative | 0.4387 | 0.5741 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.4578 | 0.5997 | 0.5155 |
Trypanosoma brucei | AMP deaminase, putative | 0.4387 | 0.5741 | 0.5 |
Echinococcus multilocularis | adenosine deaminase | 0.7565 | 1 | 1 |
Loa Loa (eye worm) | AMP deaminase | 0.4387 | 0.5741 | 0.4845 |
Echinococcus granulosus | nmda type glutamate receptor | 0.0107 | 0.0007 | 0.0007 |
Loa Loa (eye worm) | hypothetical protein | 0.4578 | 0.5997 | 0.5155 |
Leishmania major | adenosine monophosphate deaminase, putative,AMP deaminase, putative | 0.4387 | 0.5741 | 0.3057 |
Echinococcus multilocularis | AMP deaminase 2 | 0.4387 | 0.5741 | 0.5741 |
Leishmania major | AMP deaminase, putative,amp deaminase-like protein | 0.4387 | 0.5741 | 0.3057 |
Entamoeba histolytica | adenosine deaminase, putative | 0.7565 | 1 | 1 |
Trypanosoma brucei | adenosine monophosphate deaminase, putative | 0.4387 | 0.5741 | 0.5 |
Trypanosoma brucei | AMP deaminase, putative | 0.4387 | 0.5741 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.